Siemens Fonds Invest GmbH Buys Shares of 7,507 Teleflex Incorporated (NYSE:TFX)

Siemens Fonds Invest GmbH purchased a new position in Teleflex Incorporated (NYSE:TFX - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 7,507 shares of the medical technology company's stock, valued at approximately $1,336,000.

Other hedge funds have also recently made changes to their positions in the company. Norges Bank purchased a new position in Teleflex during the fourth quarter valued at $100,328,000. Invesco Ltd. increased its holdings in shares of Teleflex by 48.1% during the fourth quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company's stock valued at $190,188,000 after acquiring an additional 347,003 shares in the last quarter. Diamond Hill Capital Management Inc. purchased a new position in shares of Teleflex in the 4th quarter worth about $46,696,000. T. Rowe Price Investment Management Inc. raised its position in shares of Teleflex by 4.4% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 6,173,121 shares of the medical technology company's stock worth $1,098,693,000 after purchasing an additional 261,279 shares during the last quarter. Finally, Magnetar Financial LLC boosted its stake in Teleflex by 105.2% in the 4th quarter. Magnetar Financial LLC now owns 421,340 shares of the medical technology company's stock worth $74,990,000 after purchasing an additional 215,961 shares in the last quarter. 95.62% of the stock is owned by institutional investors.

Teleflex Price Performance

NYSE TFX opened at $129.15 on Friday. The stock has a market capitalization of $5.71 billion, a price-to-earnings ratio of 25.67, a PEG ratio of 1.73 and a beta of 1.17. Teleflex Incorporated has a 1-year low of $120.06 and a 1-year high of $249.91. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The business's fifty day moving average price is $132.83 and its 200-day moving average price is $163.14.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, beating analysts' consensus estimates of $2.88 by $0.03. The company had revenue of $700.67 million during the quarter, compared to analysts' expectations of $699.37 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Teleflex's revenue for the quarter was down 5.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $3.21 earnings per share. On average, equities analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Tuesday, May 20th will be issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.05%. The ex-dividend date is Tuesday, May 20th. Teleflex's payout ratio is 42.90%.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on TFX. Mizuho set a $155.00 price target on shares of Teleflex in a report on Wednesday, April 16th. Bank of America downgraded Teleflex from a "neutral" rating to an "underperform" rating and cut their target price for the company from $235.00 to $140.00 in a research note on Tuesday, March 4th. Piper Sandler reissued a "neutral" rating and issued a $140.00 target price (down previously from $255.00) on shares of Teleflex in a report on Friday, February 28th. Citizens Jmp cut Teleflex from an "outperform" rating to a "market perform" rating in a research note on Thursday, February 27th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Teleflex in a research report on Wednesday, March 12th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $164.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.